A phase I dose escalation trial of intravenous treosulfan in refractory cancer

Oncology Research and Treatment

Volumn 19, Issue 2, 1996, Pages 153-156

  Harstrick, A ^a   Wilke, H ^a   Eberhardt, W ^a   Klaassen, U ^a   Strumberg, D ^a   Korn, M ^a   Scheulen, M E ^a   Baumgart, J ^b   Seeber, S ^a  

^a Abteilung Innere Medizin   (Germany)

^b MEDAC GMBH   (Germany)

Author keywords

Dose escalation; Ovastat ; Phase I trial; Solid tumors; Treosulfan

Indexed keywords

ALKYLATING AGENT; TREOSULFAN;

ADULT; AGED; ARTICLE; CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; PHASE 1 CLINICAL TRIAL; THROMBOCYTOPENIA;

EID: 0029929980     PISSN: 22965270     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218782     Document Type: Article

References (13)

1. Feit PW: Stereoisomere 1,4-Di-O-Methansulfonyl-Butan-2,3,4,4-Tetrole. Tetrahedron Lett 1961:20: 716-717.
2. Feit PW, Rastrup-Andersen N, Matagne R: Studies on epoxide formation from (2S.3S)-1.2-cpoxy-3,4-hutancdiol 4-methanesulfonatc. J Med Chem 1970: 13:1173-1175.
3. White FR: L-Treitol dimethanesulfonatc. Cancer Chemother Rep 1962:24:95-97.
4. Kopf-Maier P, SaB G: Antitumor activity of treo-sulfan against human breast carcinomas. Cancer Chemother Pharmacol 1992:31:103-110.
5. Köpf-Maier P, Saß G: Antitumor activity of treo-sulfan against human lung carcinomas. Proc 8th NCI-EORTC Symp. Amsterdam. 1994. Abstract No. 062.
6. Fennelly JJ: Treosulfan (dihydroxybusulfan) in the management of ovarian carcinoma. Br J Obstet Gynaecol 1977:84:300-303.
7. Masding JE, Sarkar TK, White WF, Barley VL, Chawla SL, Boesen E, Rostom AY, Monday AP: Intravenous treosulfan versus intravenous treosulfan plus cispla-linum in advanced ovarian carcinoma. Br J Obstet Gynaecol 1990:97:342-351.
8. Breitbach GP, Villena C, Schwickerath J, Kunz T, I lurst U, Schmidt-Rhode P, Friedrich EJ, Artmeyer E, Schröder M, Eberl M, Franck J, Meinen K, Schiller S, Wernicke K, Saß G, Schmid H, Basiert G: Treosulfan bei fortgeschrittenem Ovarialc-arcinom: Bine Phase Ill-Studie. Arch Gynecol Obstet 1994:255(suppl 1):80.
9. Abdulla U, Makanji HH, Cox C Alsaidi TK, White WF, Masding JE: Chemotherapy of advanced ovarian carcinoma. Use of intravenous treosulfan in previously untreated disease. Proc 13th Int Congr Chemotherapy. Vienna. Austria. 1983.
10. Meier W, Gropp M, Hepp H: Efficacy of treosulfan in platinum refractory ovarian cancer. Proc 31st Annu Meet Am Soc Clinical Oncology. Los Angeles. CA. May 1995. Abstract No. 734.
11. Merkle E: Behandlung des metastasierten Ovarialkar/inoms mit Cisplatin und Treosulfan. Aktuel Onkol 1988:45:35-45.
12. Feit PW: Treosulfan. eine Spczialform aus der Gruppe der Alkylantien. Aktuel Onkol 1988;45:9-18.
13. Buser K, Junge FW, Joss R, Brunner KW: Chemotherapie des fortgeschrittenen Ovarialkarzinoms mit intravenös verabreichtem Dihydroxybusulfan (Treosulfan). Aktuel Onkol 1988:45:19-28.